Choose HA†
Prescribing Information: DUROLANE, GELSYN-3, SUPARTZ FX

Not all HAs are created equal

Why providers and practices choose our therapies for knee OA patients

  • Only company that offers a full portfolio of 3 HA treatment options
  • Comprehensive benefits investigation support
  • Flexible ordering options

IDNpage_Middle_Section-2

For treatment of osteoarthritis (OA) knee pain, Bioventus is the only company to combine a complete hyaluronic acid (HA) product portfolio that meets the diverse needs of health systems.

Reasons to choose Bioventus:

  • Bioventus’ 1-, 3- and 5-injection HA solutions
  • MyBV360, a comprehensive practice support tool
  • Flexible ordering options
  • Our large, dedicated sales staff with a focused commitment to patient care

Our HA solutions

With three clinically validated HA treatments, you can find the option that meets the needs of your practice and patients.

Durolane Logo

DUROLANE single-injection HA therapy:

  • The highest reported molecular weight of any HA — 1015 kDa‡43,46
  • A total joint residence time of approximately 150 days based on a half-life of 30 days35
  • Clinically equivalent performance to five-injection HA therapy24
Choose DUROLANE
Gelsyn Logo

GELSYN-3 three-injection HA therapy:

  • Since 2002, nearly 5 million GELSYN-3 syringes sold in 19 countries45
  • Clinically equivalent to higher molecular weight Synvisc® in providing pain relief for 6 months9
  • Fewer treatment-related adverse events compared to Synvisc in a clinical study9
Choose GELSYN-3
Supartz_centered_720x200

SUPARTZ FX five-injection HA therapy:

  • Approved for a five-injection regimen, although some people may benefit from receiving as few as three injections16
  • Unmatched experience, with more than 520 million injections worldwide47
  • A flexible, affordable, direct-purchase option to meet patient needs
Choose SUPARTZ FX
Running towards his goals

MyBV360: Full-service practice support

Easily manage all HA needs from Bioventus in one place. Log into the MyBV360 portal to:

  • Access insurance coverage reference tools
  • Submit benefit investigations
  • Order our HA products—with one-day delivery on most orders
  • View and pay Bioventus invoices
  • And much more!

Flexible ordering options

  • Order directly from your local Bioventus Sales Representative.
  • Call Bioventus Customer Service at 1-800-836-4080.
  • Order online at MyBV360.com.
  • Place orders with your preferred wholesale or specialty distribution partner.

 

Here to help

Bioventus’ large, dedicated sales team is committed to understanding your needs and answering your questions. Each time you contact us, you will have your representative’s specialized expertise in helping your practice find success with our products.

Please use this form to send your questions and comments:

    I am a:












     

    Bioventus is a global provider of innovations for active healing. Our clinically effective, cost efficient, minimally invasive medical treatments engage and enhance the body’s natural healing processes. Our restorative therapies, pain therapies, and surgical solutions help more than 600,000 people regain active lifestyles each year.

    ‡Based on theoretical calculations

    DUROLANE, GELSYN-3 and SUPARTZ FX are indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacological therapy or simple analgesics, e.g., acetaminophen. Risks include general knee pain and pain at the injection site.

    View Use and Important Safety Information at: DUROLANE.com, GELSYN3.com, and SUPARTZFX.COM

    Summary of Indications for Use:
    DUROLANE is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacological therapy or simple analgesics, e.g. acetaminophen.

    Do not inject DUROLANE in patients with knee joint infections, skin diseases, or other infections in the area of the injection site. Do not administer to patients with known hypersensitivity or allergy to sodium hyaluronate preparations. Risks can include transient pain or swelling at the injection site.

    DUROLANE has not been tested in pregnant or lactating women, or children.

    Full prescribing information can be found in product labeling, or by contacting Bioventus Customer Service at 800-836-4080.

    Summary of Indications for Use:
    GELSYN-3 is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics (e.g., acetaminophen). Do not administer to patients with known hypersensitivity (allergy) to sodium hyaluronate preparations. Do not inject GELSYN-3 into the knees of patients having knee joint infections or skin diseases or infections in the area of the injection site.

    GELSYN-3 is not approved for pregnant or nursing women, or children. Risks can include general knee pain, warmth and redness or pain at the injection site.

    Full prescribing information can be found in product labeling, or by contacting Bioventus Customer Service at 800-836-4080.

    Summary of Indications for Use:
    SUPARTZ FX is indicated for treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics, e.g., acetaminophen. You should not use SUPARTZ FX if you have infections or skin diseases at the injection site or allergies to poultry products. SUPARTZ FX is not approved for pregnant or nursing women, or children. Risks can include general knee pain, warmth and redness or pain at the injection site.

    Full prescribing information can be found in product labeling, or by contacting Bioventus Customer Service at 800-836-4080.